154 related articles for article (PubMed ID: 8114951)
1. Attenuation of the ischaemia-induced fall of electrical ventricular fibrillation threshold by a calcium antagonist, diltiazem.
Aupetit JF; Timour Q; Chevrel G; Loufoua-Moundanga J; Omar S; Faucon G
Naunyn Schmiedebergs Arch Pharmacol; 1993 Nov; 348(5):509-14. PubMed ID: 8114951
[TBL] [Abstract][Full Text] [Related]
2. [Value of calcium channel blockers in the prevention of ventricular fibrillation of ischemic etiology: experimental arguments].
Timour Q; Freysz M; Aupetit JF; Loufoua J; Frassati D; Faucon G
Bull Acad Natl Med; 1996 Jan; 180(1):215-26; discussion 226-7. PubMed ID: 8696877
[TBL] [Abstract][Full Text] [Related]
3. Calcium channel modulators and susceptibility to ischaemic ventricular fibrillation: modification of cellular calcium overload.
Timour Q; Larbre JP; Kioueh I; Aupetit JF; Loufoua-Moundanga J; Vialle A; Faucon G
Arch Int Pharmacodyn Ther; 1992; 315():30-46. PubMed ID: 1384452
[TBL] [Abstract][Full Text] [Related]
4. Ischaemia-induced loss or reversal of the effects of the class I antiarrhythmic drugs on vulnerability to fibrillation.
Aupetit JF; Loufoua-Moundanga J; Faucon G; Timour Q
Br J Pharmacol; 1997 Feb; 120(3):523-9. PubMed ID: 9031759
[TBL] [Abstract][Full Text] [Related]
5. Disappearance with ischaemic depolarization of the antifibrillatory activity in a sodium channel blocker and appearance in calcium channel blocker.
Bui-Xuan B; Aupetit JF; Freysz M; Loufoua-Moundanga J; Faucon G; Timour Q
Arch Int Pharmacodyn Ther; 1996; 331(3):246-62. PubMed ID: 9124997
[TBL] [Abstract][Full Text] [Related]
6. Prevention by calcium antagonists of profibrillatory effects of class I antiarrhythmic drugs in acute myocardial ischemia: study in pig heart in situ.
Bui-Xuan B; Aupetit JF; Freysz M; Faucon G; Timour Q
Pharmacotherapy; 1997; 17(4):737-45. PubMed ID: 9250551
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a beta-adrenergic receptor antagonist, propranolol, in preventing ischaemic ventricular fibrillation: dependence on heart rate and ischaemia duration.
Aupetit JF; Frassati D; Bui-Xuan B; Freysz M; Faucon G; Timour Q
Cardiovasc Res; 1998 Mar; 37(3):646-55. PubMed ID: 9659448
[TBL] [Abstract][Full Text] [Related]
8. Magnesium--a profibrillatory or antifibrillatory drug depending on plasma concentration, heart rate and myocardial perfusion.
Aupetit JF; Freysz M; Faucon G; Loufoua-Moundanga J; Coquelin H; Timour Q
Acta Anaesthesiol Scand; 1997 Apr; 41(4):516-23. PubMed ID: 9150782
[TBL] [Abstract][Full Text] [Related]
9. Delay by a calcium antagonist, amlodipine, of the onset of primary ventricular fibrillation in myocardial ischemia.
Timour Q; Bui-Xuan B; Faucon G; Aupetit JF
Cardiovasc Drugs Ther; 1996 Sep; 10(4):447-54. PubMed ID: 8924058
[TBL] [Abstract][Full Text] [Related]
10. Calcium antagonists and prevention of ventricular fibrillation induced by transient or persistent ischemia.
Timour Q; Bui-Xuan B; Aupetit JF; Freysz M; Evreux JC; Faucon G
Jpn Heart J; 1997 Mar; 38(2):237-51. PubMed ID: 9201111
[TBL] [Abstract][Full Text] [Related]
11. Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization.
Aupetit JF; Bui-Xuan B; Kioueh I; Loufoua J; Frassati D; Timour Q
Can J Physiol Pharmacol; 2000 Mar; 78(3):208-16. PubMed ID: 10721812
[TBL] [Abstract][Full Text] [Related]
12. Effects of diltiazem upon experimental ventricular dysrhythmias.
Patterson E; Eller BT; Lucchesi BR
J Pharmacol Exp Ther; 1983 Apr; 225(1):224-33. PubMed ID: 6834274
[TBL] [Abstract][Full Text] [Related]
13. Bupivacaine hastens the ischemia-induced decrease of the electrical ventricular fibrillation threshold.
Freysz M; Timour Q; Bertrix L; Loufoua J; Aupetit JF; Faucon G
Anesth Analg; 1995 Apr; 80(4):657-63. PubMed ID: 7893014
[TBL] [Abstract][Full Text] [Related]
14. Cardiac beta-adrenoreceptor activation and ventricular fibrillation under normal and ischemic conditions.
Bui-Xuan B; Aupetit JF; Freysz M; Loufoua J; Faucon G; Timour Q
Cardiovasc Res; 1996 Dec; 32(6):1056-63. PubMed ID: 9035900
[TBL] [Abstract][Full Text] [Related]
15. Potent antifibrillatory effect of combined blockade of calcium channels and 5-HT2 receptors with nexopamil during myocardial ischemia and reperfusion in dogs: comparison to diltiazem.
Nearing BD; Hutter JJ; Verrier RL
J Cardiovasc Pharmacol; 1996 Jun; 27(6):777-87. PubMed ID: 8761843
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of haemodynamic stabilisation and beta blockade on ventricular fibrillation threshold in coronary artery ligated pigs.
Muller CA; Kralios AC
Cardiovasc Res; 1993 Feb; 27(2):274-8. PubMed ID: 8097133
[TBL] [Abstract][Full Text] [Related]
17. Effects of mibefradil, a novel calcium channel blocking agent with T-type activity, in acute experimental myocardial ischemia: maintenance of ventricular fibrillation threshold without inotropic compromise.
Muller CA; Opie LH; McCarthy J; Hofmann D; Pineda CA; Peisach M
J Am Coll Cardiol; 1998 Jul; 32(1):268-74. PubMed ID: 9669280
[TBL] [Abstract][Full Text] [Related]
18. Ro 40-5967, a novel calcium channel antagonist, protects against ventricular fibrillation.
Billman GE
Eur J Pharmacol; 1992 Dec; 229(2-3):179-87. PubMed ID: 1490522
[TBL] [Abstract][Full Text] [Related]
19. Change of a beneficial effect into an untoward effect by ischaemia: effect of quinidine-like drugs on vulnerability to ventricular fibrillation.
Aupetit JF; Freysz M; Faucon G; Loufoua J; Timour Q
Environ Toxicol Pharmacol; 1996 Aug; 2(1):1-7. PubMed ID: 21781694
[TBL] [Abstract][Full Text] [Related]
20. The effects of mibefradil, a novel calcium channel antagonist on ventricular arrhythmias induced by myocardial ischemia and programmed electrical stimulation.
Billman GE; Hamlin RL
J Pharmacol Exp Ther; 1996 Jun; 277(3):1517-26. PubMed ID: 8667218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
